HIGH-AFFINITY [H-3] GBR 12783 BINDING TO A SPECIFIC SITE ASSOCIATED WITH THE NEURONAL DOPAMINE UPTAKE COMPLEX IN THE CENTRAL-NERVOUS-SYSTEM

被引:115
作者
BONNET, JJ [1 ]
PROTAIS, P [1 ]
CHAGRAOUI, A [1 ]
COSTENTIN, J [1 ]
机构
[1] UER MED & PHARM ROUEN, PHARMACODYNAM & PHYSIOL LAB,CNRS,UNITE 1170, AVE UNIV,BP 97, F-76800 ST ETIENNE DU ROUVRAY, FRANCE
关键词
D O I
10.1016/0014-2999(86)90050-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:211 / 222
页数:12
相关论文
共 30 条
[1]   [H-3] GBR-12935 - A SPECIFIC HIGH-AFFINITY LIGAND FOR LABELING THE DOPAMINE TRANSPORT COMPLEX [J].
BERGER, P ;
JANOWSKY, A ;
VOCCI, F ;
SKOLNICK, P ;
SCHWERI, MM ;
PAUL, SM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 107 (02) :289-290
[2]   GBR-12783, A POTENT AND SELECTIVE INHIBITOR OF DOPAMINE UPTAKE - BIOCHEMICAL-STUDIES INVIVO AND EXVIVO [J].
BONNET, JJ ;
COSTENTIN, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 121 (02) :199-209
[3]   SIMULTANEOUS EVALUATION BY A DOUBLE LABELING METHOD OF DRUG-INDUCED UPTAKE INHIBITION AND RELEASE OF DOPAMINE IN SYNAPTOSOMAL PREPARATION OF RAT STRIATUM [J].
BONNET, JJ ;
LEMASSON, MH ;
COSTENTIN, J .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (13) :2129-2135
[4]   SODIUM DEPENDENCY OF [H-3]IMIPRAMINE BINDING IN RAT CEREBRAL-CORTEX [J].
BRILEY, M ;
LANGER, SZ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 72 (04) :377-380
[5]   BINDING CHARACTERISTICS OF THE DOPAMINE UPTAKE INHIBITOR [H-3] NOMIFENSINE TO STRIATAL MEMBRANES [J].
DUBOCOVICH, ML ;
ZAHNISER, NR .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (08) :1137-1144
[6]  
FISCHER JF, 1979, J PHARMACOL EXP THER, V208, P203
[7]   STUDIES ON DISTINCTION BETWEEN UPTAKE INHIBITION AND RELEASE OF [H-3] DOPAMINE IN RAT-BRAIN TISSUE-SLICES [J].
HEIKKILA, RE ;
ORLANSKY, H ;
COHEN, G .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (08) :847-852
[9]  
JACOBOWITZ DM, 1978, PSYCHOPHARMACOLOGY G, P119
[10]   THE EFFECTS OF SURGICAL AND CHEMICAL LESIONS ON STRIATAL [H-3]THREO-(+/-)-METHYLPHENIDATE BINDING - CORRELATION WITH [H-3]DOPAMINE UPTAKE [J].
JANOWSKY, A ;
SCHWERI, MM ;
BERGER, P ;
LONG, R ;
SKOLNICK, P ;
PAUL, SM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 108 (02) :187-191